EverSource Wealth Advisors’s Zai Lab ZLAB Stock Holding History

EverSource Wealth Advisors’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.22K	Sell	117 -67	-36%	-$1.32K	﹤0.01%	3683
2026 Q1	$3.46K	Sell	184 -19	-9%	-$352	﹤0.01%	3433
2025 Q4	$3.58K	Buy	203 +27	+15%	+$632	﹤0.01%	3257
2025 Q3	$5.96K	Buy	176 +14	+9%	+$482	﹤0.01%	3079
2025 Q2	$5.67K	Buy	162 +11	+7%	+$362	﹤0.01%	3109
2025 Q1	$5.46K	Buy	151 +53	+54%	+$1.63K	﹤0.01%	2452
2024 Q4	$2.57K	Buy	98 +3	+3%	+$83	﹤0.01%	2621
2024 Q3	$2.29K	Buy	95 +1	+1%	+$19	﹤0.01%	2506
2024 Q2	$1.79K	Sell	94 -62	-40%	-$1.09K	﹤0.01%	2585
2024 Q1	$2.46K	Buy	+156	New	+$3.29K	﹤0.01%	2318
2022 Q4	–	Sell	-810	Closed	-$28K	–	2440
2022 Q3	$28K	Buy	+810	New	+$34.7K	0.01%	798

Other funds holding ZLAB

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

EverSource Wealth Advisors's ZLAB Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Zai Lab (ZLAB) stake by 36% in Q2 2026, selling an estimated $1.32K and leaving 117 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #3683.

EverSource Wealth Advisors first reported a position in ZLAB in Q3 2022 and has held it in 11 quarters since. The position peaked at $28K in Q3 2022. 92 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

EverSource Wealth Advisors held 117 shares of Zai Lab worth $2.22K as of Q2 2026.
EverSource Wealth Advisors sold 67 Zai Lab shares in Q2 2026, an estimated $1.32K.
Zai Lab made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3683 holding.
EverSource Wealth Advisors first reported a position in Zai Lab in Q3 2022 and has held it in 11 quarters since.
EverSource Wealth Advisors's Zai Lab position peaked at $28K in Q3 2022.
92 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.